New hope for kidney cancer treatment using existing drugs

AI nuclear energy background, future innovation of disruptive technology

The most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat renal cell carcinoma, a cancer with a high mortality rate that is hard to detect. Researchers from the Wellcome Sanger Institute, the University of Cambridge and Cambridge University Hospitals identified immune cells known as macrophages that express the gene IL1B as crucial to tumor development.

We’re told to ‘eat a rainbow’ of fruit and vegetables: Here’s what each color does in our body

Previous article

How Plum Is Simplifying Real Estate and Vacation Co-Ownership

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations